From GlobeNewswire: 2025-04-12 08:00:00

The Women’s Health Diagnostics Market is projected to reach USD 49.00 billion by 2032, fueled by advancements in diagnostic technologies and increased awareness of women’s health issues. The US held a 38% share in 2023, with breast cancer being the most prevalent cancer among American women. Technological innovations like AI and genetic testing are driving market growth. Key companies include F. Hoffmann-La Roche Ltd., Hologic, Inc., and Abbott.

Innovations like liquid biopsies and portable bone density scanners are enhancing diagnostic accuracy, while AI in imaging is reducing human errors. Market growth is also driven by increasing awareness through advocacy organizations and digital health platforms. However, challenges such as high diagnostic costs and healthcare access disparities may hinder growth.

The cancer diagnostics segment dominated the market in 2023, with mammography, MRI, and liquid biopsy tests for breast cancer being key options. Hospitals remain the primary end-use for diagnostic tests, with diagnostic labs and clinics also playing significant roles. The rise of point-of-care testing and government initiatives like free mammogram programs are contributing to market growth. The Women’s Health Diagnostics Market is segmented by application (cancer, infectious diseases, osteoporosis, pregnancy & fertility, prenatal) and end-use (hospitals, laboratory, home care, others). North America led in 2023 with 44.31% of global revenue, driven by high healthcare costs and strong diagnostic infrastructure. Europe followed, with countries like Germany and the U.K. promoting national cancer screening programs. The fastest-growing market is in the Asia-Pacific region, fueled by increased healthcare investment and awareness.

Recent developments include Hologic Inc.’s launch of a next-generation 3D mammography system with AI-powered imaging for early breast cancer diagnosis. Siemens Healthineers gained FDA approval for its high-risk HPV DNA assay, enhancing cervical cancer screening accuracy. The market outlook report from 2024-2032 offers insights on incidence and prevalence of women’s health conditions, technological advancements, adoption rates of early screening programs, and more.

SNS Insider is a top market research and consulting agency providing valuable insights for clients to navigate changing market conditions. Using various techniques like surveys and focus groups, they offer accurate market data and consumer insights to help clients make informed decisions confidently. For more information or customization research, contact [email protected].

Read more at GlobeNewswire: Women’s Health Diagnostics Market Size to Hit USD 49.00